Review





Similar Products

97
R&D Systems nmol l tumor necrosis factor
Nmol L Tumor Necrosis Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nmol l tumor necrosis factor/product/R&D Systems
Average 97 stars, based on 1 article reviews
nmol l tumor necrosis factor - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

96
R&D Systems factor κb ligand
Factor κb Ligand, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/factor κb ligand/product/R&D Systems
Average 96 stars, based on 1 article reviews
factor κb ligand - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

86
Novoprotein recombinant tnf α
Characterization of Res-PD-L1@nmEVs . (A) Schematic illustration of the Res-PD-L1@nmEVs synthesis procedure. (B-D) Representative transmission electron microscopy (TEM) images, dynamic light scattering (DLS) size distributions, and zeta potential measurements of nEVs, PD-L1@mEVs, PD-L1@nmEVs, and Res-PD-L1@nmEVs. (E) PD-L1 expression in PD-L1-overexpressing MSCs (OE-PD-L1) and negative control (NC) MSCs, and CD11b expression in HL60 cells before and after DMSO stimulation, as determined by Western blot. (F) Expression levels of neutrophil membrane markers (CD11b, CXCR2, RAGE, TLR2) and the exosomal marker CD63 in the four EV types. (G) Fluorescence co-localization images of DiO-labeled nEVs (green) and DiL-labeled PD-L1@mEVs (red) after fusion, demonstrating hybrid vesicle formation. (H) Size stability of Res-PD-L1@nmEVs stored at 4 °C and 37 °C for 7 days. (I-K) Binding and neutralization capacity of Res-PD-L1@nmEVs against inflammatory cytokines <t>(TNF-α,</t> IL-6, IL-1β) in vitro. ∗ vs. 0ug/ml; # vs. 100 μg/ml, p < 0.05, n = 5.
Recombinant Tnf α, supplied by Novoprotein, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant tnf α/product/Novoprotein
Average 86 stars, based on 1 article reviews
recombinant tnf α - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

94
Bio X Cell anti mouse tim 3
Characterization of Res-PD-L1@nmEVs . (A) Schematic illustration of the Res-PD-L1@nmEVs synthesis procedure. (B-D) Representative transmission electron microscopy (TEM) images, dynamic light scattering (DLS) size distributions, and zeta potential measurements of nEVs, PD-L1@mEVs, PD-L1@nmEVs, and Res-PD-L1@nmEVs. (E) PD-L1 expression in PD-L1-overexpressing MSCs (OE-PD-L1) and negative control (NC) MSCs, and CD11b expression in HL60 cells before and after DMSO stimulation, as determined by Western blot. (F) Expression levels of neutrophil membrane markers (CD11b, CXCR2, RAGE, TLR2) and the exosomal marker CD63 in the four EV types. (G) Fluorescence co-localization images of DiO-labeled nEVs (green) and DiL-labeled PD-L1@mEVs (red) after fusion, demonstrating hybrid vesicle formation. (H) Size stability of Res-PD-L1@nmEVs stored at 4 °C and 37 °C for 7 days. (I-K) Binding and neutralization capacity of Res-PD-L1@nmEVs against inflammatory cytokines <t>(TNF-α,</t> IL-6, IL-1β) in vitro. ∗ vs. 0ug/ml; # vs. 100 μg/ml, p < 0.05, n = 5.
Anti Mouse Tim 3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse tim 3/product/Bio X Cell
Average 94 stars, based on 1 article reviews
anti mouse tim 3 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
R&D Systems recombinant human vegfr1 flt 1 fc chimera protein
Characterization of Res-PD-L1@nmEVs . (A) Schematic illustration of the Res-PD-L1@nmEVs synthesis procedure. (B-D) Representative transmission electron microscopy (TEM) images, dynamic light scattering (DLS) size distributions, and zeta potential measurements of nEVs, PD-L1@mEVs, PD-L1@nmEVs, and Res-PD-L1@nmEVs. (E) PD-L1 expression in PD-L1-overexpressing MSCs (OE-PD-L1) and negative control (NC) MSCs, and CD11b expression in HL60 cells before and after DMSO stimulation, as determined by Western blot. (F) Expression levels of neutrophil membrane markers (CD11b, CXCR2, RAGE, TLR2) and the exosomal marker CD63 in the four EV types. (G) Fluorescence co-localization images of DiO-labeled nEVs (green) and DiL-labeled PD-L1@mEVs (red) after fusion, demonstrating hybrid vesicle formation. (H) Size stability of Res-PD-L1@nmEVs stored at 4 °C and 37 °C for 7 days. (I-K) Binding and neutralization capacity of Res-PD-L1@nmEVs against inflammatory cytokines <t>(TNF-α,</t> IL-6, IL-1β) in vitro. ∗ vs. 0ug/ml; # vs. 100 μg/ml, p < 0.05, n = 5.
Recombinant Human Vegfr1 Flt 1 Fc Chimera Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human vegfr1 flt 1 fc chimera protein/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant human vegfr1 flt 1 fc chimera protein - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
Bio X Cell recombinant flt 3l ig
Characterization of Res-PD-L1@nmEVs . (A) Schematic illustration of the Res-PD-L1@nmEVs synthesis procedure. (B-D) Representative transmission electron microscopy (TEM) images, dynamic light scattering (DLS) size distributions, and zeta potential measurements of nEVs, PD-L1@mEVs, PD-L1@nmEVs, and Res-PD-L1@nmEVs. (E) PD-L1 expression in PD-L1-overexpressing MSCs (OE-PD-L1) and negative control (NC) MSCs, and CD11b expression in HL60 cells before and after DMSO stimulation, as determined by Western blot. (F) Expression levels of neutrophil membrane markers (CD11b, CXCR2, RAGE, TLR2) and the exosomal marker CD63 in the four EV types. (G) Fluorescence co-localization images of DiO-labeled nEVs (green) and DiL-labeled PD-L1@mEVs (red) after fusion, demonstrating hybrid vesicle formation. (H) Size stability of Res-PD-L1@nmEVs stored at 4 °C and 37 °C for 7 days. (I-K) Binding and neutralization capacity of Res-PD-L1@nmEVs against inflammatory cytokines <t>(TNF-α,</t> IL-6, IL-1β) in vitro. ∗ vs. 0ug/ml; # vs. 100 μg/ml, p < 0.05, n = 5.
Recombinant Flt 3l Ig, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant flt 3l ig/product/Bio X Cell
Average 94 stars, based on 1 article reviews
recombinant flt 3l ig - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

86
Servicebio Inc gnrh6 crm197 recombinant protein
SDS-PAGE analysis of expression of <t>pET21a-GnRH6-CRM197</t> in E. coli. BL21. Lane 1, standard molecular weight marker; Lane 2, non-induced recombinant bacteria; Lane 3, recombinant bacteria induced after 12 h.
Gnrh6 Crm197 Recombinant Protein, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gnrh6 crm197 recombinant protein/product/Servicebio Inc
Average 86 stars, based on 1 article reviews
gnrh6 crm197 recombinant protein - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

97
R&D Systems recombinant human egf
SDS-PAGE analysis of expression of <t>pET21a-GnRH6-CRM197</t> in E. coli. BL21. Lane 1, standard molecular weight marker; Lane 2, non-induced recombinant bacteria; Lane 3, recombinant bacteria induced after 12 h.
Recombinant Human Egf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human egf/product/R&D Systems
Average 97 stars, based on 1 article reviews
recombinant human egf - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

96
R&D Systems rank l
SDS-PAGE analysis of expression of <t>pET21a-GnRH6-CRM197</t> in E. coli. BL21. Lane 1, standard molecular weight marker; Lane 2, non-induced recombinant bacteria; Lane 3, recombinant bacteria induced after 12 h.
Rank L, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rank l/product/R&D Systems
Average 96 stars, based on 1 article reviews
rank l - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

86
Simplot Science potential recombination events
Results of the <t>recombination</t> analysis of the XH2109 strain. Strains were subjected to similarity plot using SimPlot version 3.5.1. A. Recombination analysis results of the XH2109 strain against FAdV-8a ( KT862810 ), FAdV-8b ( KT862811 ), CH/GDLZ/201801 ( MK387061 ), and CH/HBXT/1907 ( OM868085.1 ). The blue, yellow, red and green peak plots represent FAdV-8a, FAdV-8b, CH/HBXT/1907 and CH/GDLZ/201801, respectively. B Recombination analysis results of the XH2109 strain against six recent Chinese FAdV-8a and FAdV-8b strains. The yellow, blue, gray, pink, red, and green peak plots represent HD2402 ( WXX18678.1 ), HeB20 ( UWT60572.1 ), QD2016 ( AWT08526.1 ), SD1356 ( AYC35465.1 ), SD2009 ( UXL82796.1 ), and JL170408 ( MN417117.1 ), respectively.
Potential Recombination Events, supplied by Simplot Science, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/potential recombination events/product/Simplot Science
Average 86 stars, based on 1 article reviews
potential recombination events - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Characterization of Res-PD-L1@nmEVs . (A) Schematic illustration of the Res-PD-L1@nmEVs synthesis procedure. (B-D) Representative transmission electron microscopy (TEM) images, dynamic light scattering (DLS) size distributions, and zeta potential measurements of nEVs, PD-L1@mEVs, PD-L1@nmEVs, and Res-PD-L1@nmEVs. (E) PD-L1 expression in PD-L1-overexpressing MSCs (OE-PD-L1) and negative control (NC) MSCs, and CD11b expression in HL60 cells before and after DMSO stimulation, as determined by Western blot. (F) Expression levels of neutrophil membrane markers (CD11b, CXCR2, RAGE, TLR2) and the exosomal marker CD63 in the four EV types. (G) Fluorescence co-localization images of DiO-labeled nEVs (green) and DiL-labeled PD-L1@mEVs (red) after fusion, demonstrating hybrid vesicle formation. (H) Size stability of Res-PD-L1@nmEVs stored at 4 °C and 37 °C for 7 days. (I-K) Binding and neutralization capacity of Res-PD-L1@nmEVs against inflammatory cytokines (TNF-α, IL-6, IL-1β) in vitro. ∗ vs. 0ug/ml; # vs. 100 μg/ml, p < 0.05, n = 5.

Journal: Bioactive Materials

Article Title: Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia–reperfusion lung injury and pneumonia

doi: 10.1016/j.bioactmat.2026.03.024

Figure Lengend Snippet: Characterization of Res-PD-L1@nmEVs . (A) Schematic illustration of the Res-PD-L1@nmEVs synthesis procedure. (B-D) Representative transmission electron microscopy (TEM) images, dynamic light scattering (DLS) size distributions, and zeta potential measurements of nEVs, PD-L1@mEVs, PD-L1@nmEVs, and Res-PD-L1@nmEVs. (E) PD-L1 expression in PD-L1-overexpressing MSCs (OE-PD-L1) and negative control (NC) MSCs, and CD11b expression in HL60 cells before and after DMSO stimulation, as determined by Western blot. (F) Expression levels of neutrophil membrane markers (CD11b, CXCR2, RAGE, TLR2) and the exosomal marker CD63 in the four EV types. (G) Fluorescence co-localization images of DiO-labeled nEVs (green) and DiL-labeled PD-L1@mEVs (red) after fusion, demonstrating hybrid vesicle formation. (H) Size stability of Res-PD-L1@nmEVs stored at 4 °C and 37 °C for 7 days. (I-K) Binding and neutralization capacity of Res-PD-L1@nmEVs against inflammatory cytokines (TNF-α, IL-6, IL-1β) in vitro. ∗ vs. 0ug/ml; # vs. 100 μg/ml, p < 0.05, n = 5.

Article Snippet: These cells were then stimulated with 40 ng/mL recombinant TNF-α (C008, Novoprotein, China) for 6 h to induce an N1-type neutrophil phenotype.

Techniques: Transmission Assay, Electron Microscopy, Zeta Potential Analyzer, Expressing, Negative Control, Western Blot, Membrane, Marker, Fluorescence, Labeling, Binding Assay, Neutralization, In Vitro

Res-PD-L1@nmEVs Attenuate Inflammation and Oxidative Damage in Lung Epithelial Cells In Vitro . (A-B) Flow cytometric analysis and quantification (B) of DiO-labeled Res-PD-L1@nmEVs uptake by BEAS-2B cells under H/R conditions after pretreatment with different endocytic inhibitors (chlorpromazine, chloroquine, and filipin) or incubation at 4 °C. (C) mRNA expression levels of IL-6, TNF-α, and IL-1β in BEAS-2B cells with or without H/R injury following pretreatment with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs. (D-E) Representative fluorescence images (D) and quantitative analysis (E) of cell proliferation assessed by BrdU incorporation (red; nuclei stained with DAPI, blue). Scale bar: 50 μm. (F-G) Apoptosis rates detected by flow cytometry (F) and flow cytometric analysis of Annexin V-positive BEAS-2B cells under the indicated conditions (G). (H–K) Fluorescence microscopy images and quantitative analysis of intracellular nitric oxide (NO, green) (H-I) and reactive oxygen species (ROS, red) (J-K). Scale bar: 100 μm. (L) Flow cytometry analysis of intracellular ROS levels. (M − O) Levels of malondialdehyde (MDA) (M), superoxide dismutase 2 (SOD2) activity (N), and glutathione (GSH) content (O) in cells. (P-Q) Cell migration ability evaluated by wound healing assay under different treatments. ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.

Journal: Bioactive Materials

Article Title: Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia–reperfusion lung injury and pneumonia

doi: 10.1016/j.bioactmat.2026.03.024

Figure Lengend Snippet: Res-PD-L1@nmEVs Attenuate Inflammation and Oxidative Damage in Lung Epithelial Cells In Vitro . (A-B) Flow cytometric analysis and quantification (B) of DiO-labeled Res-PD-L1@nmEVs uptake by BEAS-2B cells under H/R conditions after pretreatment with different endocytic inhibitors (chlorpromazine, chloroquine, and filipin) or incubation at 4 °C. (C) mRNA expression levels of IL-6, TNF-α, and IL-1β in BEAS-2B cells with or without H/R injury following pretreatment with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs. (D-E) Representative fluorescence images (D) and quantitative analysis (E) of cell proliferation assessed by BrdU incorporation (red; nuclei stained with DAPI, blue). Scale bar: 50 μm. (F-G) Apoptosis rates detected by flow cytometry (F) and flow cytometric analysis of Annexin V-positive BEAS-2B cells under the indicated conditions (G). (H–K) Fluorescence microscopy images and quantitative analysis of intracellular nitric oxide (NO, green) (H-I) and reactive oxygen species (ROS, red) (J-K). Scale bar: 100 μm. (L) Flow cytometry analysis of intracellular ROS levels. (M − O) Levels of malondialdehyde (MDA) (M), superoxide dismutase 2 (SOD2) activity (N), and glutathione (GSH) content (O) in cells. (P-Q) Cell migration ability evaluated by wound healing assay under different treatments. ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.

Article Snippet: These cells were then stimulated with 40 ng/mL recombinant TNF-α (C008, Novoprotein, China) for 6 h to induce an N1-type neutrophil phenotype.

Techniques: In Vitro, Labeling, Incubation, Expressing, Fluorescence, BrdU Incorporation Assay, Staining, Flow Cytometry, Microscopy, Activity Assay, Migration, Wound Healing Assay, Control

Res-PD-L1@nmEVs Suppresses Neutrophil Activation HL60 cells were differentiated into neutrophil-like cells using DMSO and subsequently stimulated with TNF-α to induce activation under conditions simulating IRI. The effects of Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, and Res-PD-L1@nmEVs on neutrophil activation were evaluated. (A) Cell surface PD-1 expression analyzed by flow cytometry. (B) Representative immunofluorescence images of CD206 expression (red). Nuclei were stained with DAPI (blue). Scale bar: 50 μm. (C) Flow cytometric analysis of cell surface CD206 expression. (D) Flow cytometric analysis of cell surface CD95 expression. (E-G) Levels of myeloperoxidase (MPO) (E), neutrophil elastase (NE) (F), and MMP-9 (G) in neutrophil culture supernatants, measured by ELISA. (H-J) BEAS-2B cells were co-cultured with neutrophils in the presence or absence of TNF-α stimulation. Apoptosis levels (I) and migration capacity (J) of BEAS-2B cells were assessed under different treatment conditions. ∗ vs. Control; # vs. TNF-a; & vs. TNF-a+PD-L1@nmEVs, p < 0.05.

Journal: Bioactive Materials

Article Title: Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia–reperfusion lung injury and pneumonia

doi: 10.1016/j.bioactmat.2026.03.024

Figure Lengend Snippet: Res-PD-L1@nmEVs Suppresses Neutrophil Activation HL60 cells were differentiated into neutrophil-like cells using DMSO and subsequently stimulated with TNF-α to induce activation under conditions simulating IRI. The effects of Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, and Res-PD-L1@nmEVs on neutrophil activation were evaluated. (A) Cell surface PD-1 expression analyzed by flow cytometry. (B) Representative immunofluorescence images of CD206 expression (red). Nuclei were stained with DAPI (blue). Scale bar: 50 μm. (C) Flow cytometric analysis of cell surface CD206 expression. (D) Flow cytometric analysis of cell surface CD95 expression. (E-G) Levels of myeloperoxidase (MPO) (E), neutrophil elastase (NE) (F), and MMP-9 (G) in neutrophil culture supernatants, measured by ELISA. (H-J) BEAS-2B cells were co-cultured with neutrophils in the presence or absence of TNF-α stimulation. Apoptosis levels (I) and migration capacity (J) of BEAS-2B cells were assessed under different treatment conditions. ∗ vs. Control; # vs. TNF-a; & vs. TNF-a+PD-L1@nmEVs, p < 0.05.

Article Snippet: These cells were then stimulated with 40 ng/mL recombinant TNF-α (C008, Novoprotein, China) for 6 h to induce an N1-type neutrophil phenotype.

Techniques: Activation Assay, Expressing, Flow Cytometry, Immunofluorescence, Staining, Enzyme-linked Immunosorbent Assay, Cell Culture, Migration, Control

Res-PD-L1@nmEVs Effectively Attenuates MRSA-Induced Pneumonia (A-B) Rats with MRSA-induced pneumonia received three bronchial nebulization treatments over one week with different formulations (Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs). (A) Representative H&E-stained lung sections and (B) corresponding lung injury scores are shown (n = 5). (C) TUNEL staining of lung tissues to assess apoptosis. (D) Representative micro-CT images of anesthetized rats. (E-G) Flow cytometric analysis of immune cell proportions in lung single-cell suspensions: CD8 + T cells (E), neutrophils (F), and classical monocytes (G). (H-J) Plasma levels of inflammatory cytokines IL-6 (H), IL-1β (I), and TNF-α (J) (n = 5). (K) Immunofluorescence staining of tight junction proteins Occludin (green) and ZO-1 (red) in lung tissues (nuclei stained with DAPI). Scale bar: 50 μm. (L-N) Pulmonary function parameters: lung compliance (L), airway resistance (M), and oxygenation index (N) (n = 4). ∗ vs. Sham; # vs. MRSA; & vs. MRSA + PD-L1@nmEVs, p < 0.05.

Journal: Bioactive Materials

Article Title: Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia–reperfusion lung injury and pneumonia

doi: 10.1016/j.bioactmat.2026.03.024

Figure Lengend Snippet: Res-PD-L1@nmEVs Effectively Attenuates MRSA-Induced Pneumonia (A-B) Rats with MRSA-induced pneumonia received three bronchial nebulization treatments over one week with different formulations (Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs). (A) Representative H&E-stained lung sections and (B) corresponding lung injury scores are shown (n = 5). (C) TUNEL staining of lung tissues to assess apoptosis. (D) Representative micro-CT images of anesthetized rats. (E-G) Flow cytometric analysis of immune cell proportions in lung single-cell suspensions: CD8 + T cells (E), neutrophils (F), and classical monocytes (G). (H-J) Plasma levels of inflammatory cytokines IL-6 (H), IL-1β (I), and TNF-α (J) (n = 5). (K) Immunofluorescence staining of tight junction proteins Occludin (green) and ZO-1 (red) in lung tissues (nuclei stained with DAPI). Scale bar: 50 μm. (L-N) Pulmonary function parameters: lung compliance (L), airway resistance (M), and oxygenation index (N) (n = 4). ∗ vs. Sham; # vs. MRSA; & vs. MRSA + PD-L1@nmEVs, p < 0.05.

Article Snippet: These cells were then stimulated with 40 ng/mL recombinant TNF-α (C008, Novoprotein, China) for 6 h to induce an N1-type neutrophil phenotype.

Techniques: Staining, TUNEL Assay, Micro-CT, Single Cell, Clinical Proteomics, Immunofluorescence

SDS-PAGE analysis of expression of pET21a-GnRH6-CRM197 in E. coli. BL21. Lane 1, standard molecular weight marker; Lane 2, non-induced recombinant bacteria; Lane 3, recombinant bacteria induced after 12 h.

Journal: Poultry Science

Article Title: Immunocastration with recombinant GnRH6-CRM197 fusion protein improves reproductive suppression and meat tenderness in roosters

doi: 10.1016/j.psj.2026.107046

Figure Lengend Snippet: SDS-PAGE analysis of expression of pET21a-GnRH6-CRM197 in E. coli. BL21. Lane 1, standard molecular weight marker; Lane 2, non-induced recombinant bacteria; Lane 3, recombinant bacteria induced after 12 h.

Article Snippet: The GnRH6-CRM197 recombinant protein was separated on a 12.5% SDS polyacrylamide gel at 120 V. It was then transferred to a 0.45μm polyvinylidene fluoride (PVDF) membrane (Pulilai, Beijing, China) at 250 mA for 1 hour using a transfer system (BVT-2, Servicebio, Wuhan, China).

Techniques: SDS Page, Expressing, Molecular Weight, Marker, Recombinant, Bacteria

WB analysis of recombinant GnRH6-CRM197 protein. Lane 1, standard molecular weight marker; Lane 2, recombinant GnRH6-CRM197 fusion protein reacted with rabbit polyclonal to GnRH (dilution 1:2000) .

Journal: Poultry Science

Article Title: Immunocastration with recombinant GnRH6-CRM197 fusion protein improves reproductive suppression and meat tenderness in roosters

doi: 10.1016/j.psj.2026.107046

Figure Lengend Snippet: WB analysis of recombinant GnRH6-CRM197 protein. Lane 1, standard molecular weight marker; Lane 2, recombinant GnRH6-CRM197 fusion protein reacted with rabbit polyclonal to GnRH (dilution 1:2000) .

Article Snippet: The GnRH6-CRM197 recombinant protein was separated on a 12.5% SDS polyacrylamide gel at 120 V. It was then transferred to a 0.45μm polyvinylidene fluoride (PVDF) membrane (Pulilai, Beijing, China) at 250 mA for 1 hour using a transfer system (BVT-2, Servicebio, Wuhan, China).

Techniques: Recombinant, Molecular Weight, Marker

The effect of recombinant anti-GnRH6-CRM197 on serum anti-GnRH antibody of roosters. The arrow refers to the immune time; the first immunity of roosters is 4 W; * P < 0.05; ** P < 0.01 (n = 20 per group).

Journal: Poultry Science

Article Title: Immunocastration with recombinant GnRH6-CRM197 fusion protein improves reproductive suppression and meat tenderness in roosters

doi: 10.1016/j.psj.2026.107046

Figure Lengend Snippet: The effect of recombinant anti-GnRH6-CRM197 on serum anti-GnRH antibody of roosters. The arrow refers to the immune time; the first immunity of roosters is 4 W; * P < 0.05; ** P < 0.01 (n = 20 per group).

Article Snippet: The GnRH6-CRM197 recombinant protein was separated on a 12.5% SDS polyacrylamide gel at 120 V. It was then transferred to a 0.45μm polyvinylidene fluoride (PVDF) membrane (Pulilai, Beijing, China) at 250 mA for 1 hour using a transfer system (BVT-2, Servicebio, Wuhan, China).

Techniques: Recombinant

The effect of recombinant GnRH6-CRM197 on serum testosterone levels of roosters. * P < 0.05; ** P < 0.01 (n = 20 per group).

Journal: Poultry Science

Article Title: Immunocastration with recombinant GnRH6-CRM197 fusion protein improves reproductive suppression and meat tenderness in roosters

doi: 10.1016/j.psj.2026.107046

Figure Lengend Snippet: The effect of recombinant GnRH6-CRM197 on serum testosterone levels of roosters. * P < 0.05; ** P < 0.01 (n = 20 per group).

Article Snippet: The GnRH6-CRM197 recombinant protein was separated on a 12.5% SDS polyacrylamide gel at 120 V. It was then transferred to a 0.45μm polyvinylidene fluoride (PVDF) membrane (Pulilai, Beijing, China) at 250 mA for 1 hour using a transfer system (BVT-2, Servicebio, Wuhan, China).

Techniques: Recombinant

Results of the recombination analysis of the XH2109 strain. Strains were subjected to similarity plot using SimPlot version 3.5.1. A. Recombination analysis results of the XH2109 strain against FAdV-8a ( KT862810 ), FAdV-8b ( KT862811 ), CH/GDLZ/201801 ( MK387061 ), and CH/HBXT/1907 ( OM868085.1 ). The blue, yellow, red and green peak plots represent FAdV-8a, FAdV-8b, CH/HBXT/1907 and CH/GDLZ/201801, respectively. B Recombination analysis results of the XH2109 strain against six recent Chinese FAdV-8a and FAdV-8b strains. The yellow, blue, gray, pink, red, and green peak plots represent HD2402 ( WXX18678.1 ), HeB20 ( UWT60572.1 ), QD2016 ( AWT08526.1 ), SD1356 ( AYC35465.1 ), SD2009 ( UXL82796.1 ), and JL170408 ( MN417117.1 ), respectively.

Journal: Poultry Science

Article Title: Characterization of a natural recombinant fowl adenovirus of serotypes 8a and 8b

doi: 10.1016/j.psj.2026.106789

Figure Lengend Snippet: Results of the recombination analysis of the XH2109 strain. Strains were subjected to similarity plot using SimPlot version 3.5.1. A. Recombination analysis results of the XH2109 strain against FAdV-8a ( KT862810 ), FAdV-8b ( KT862811 ), CH/GDLZ/201801 ( MK387061 ), and CH/HBXT/1907 ( OM868085.1 ). The blue, yellow, red and green peak plots represent FAdV-8a, FAdV-8b, CH/HBXT/1907 and CH/GDLZ/201801, respectively. B Recombination analysis results of the XH2109 strain against six recent Chinese FAdV-8a and FAdV-8b strains. The yellow, blue, gray, pink, red, and green peak plots represent HD2402 ( WXX18678.1 ), HeB20 ( UWT60572.1 ), QD2016 ( AWT08526.1 ), SD1356 ( AYC35465.1 ), SD2009 ( UXL82796.1 ), and JL170408 ( MN417117.1 ), respectively.

Article Snippet: To verify potential recombination events, recombination analysis of the XH2109 strain was performed using Simplot software.

Techniques: